Canagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, attenuates pancreatic fibrosis in chronic pancreatitis through the AMPK-OPG-CTGF axis. - Adachi A; Kato H; Kato A; Yoshida M; Hori Y; Toyohara T; Oda K; Kito Y; Urakabe K; Mori T; Takahashi S; Kataoka H (Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2026)